Identifying patients at risk of supratherapeutic amisulpride exposure in routine psychiatric practice: a real-world therapeutic drug monitoring study
Therapeutic Advances in Psychopharmacology
Published online on July 07, 2026
Abstract
Therapeutic Advances in Psychopharmacology, Volume 16, January-December 2026.
Background:Amisulpride is an important antipsychotic used in the treatment of schizophrenia, yet its exposure shows inter-individual variability. Although therapeutic drug monitoring (TDM) is recommended, supratherapeutic concentrations (>600 ng/mL) still ...
Background:Amisulpride is an important antipsychotic used in the treatment of schizophrenia, yet its exposure shows inter-individual variability. Although therapeutic drug monitoring (TDM) is recommended, supratherapeutic concentrations (>600 ng/mL) still ...